Reuters logo
BRIEF-Cumberland Pharmaceuticals launches promotion of Totect in U.S. for emergency oncology intervention
September 25, 2017 / 12:20 PM / 3 months ago

BRIEF-Cumberland Pharmaceuticals launches promotion of Totect in U.S. for emergency oncology intervention

Sept 25 (Reuters) - Clinigen Group Plc

* Cumberland Pharmaceuticals launches promotion of Totect® in the U.S. for emergency oncology intervention

* Cumberland Pharmaceuticals Inc - ‍announced promotional launch of totect (dexrazoxane hydrochloride), in U.S.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below